Showing results (2241-2250 of 2,522) with videos related to
Sort By:
Pageof 253
Medical Research Archives|July 24, 2023
A Pilot Study of Neurobiological Mechanisms of Stress and Cardiovascular RiskJ Douglas Bremner, Marina Piccinelli, Ernest V Garcia, et al.Gynecologic Oncology|October 9, 2020
Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and cold knife cone biopsyPaul A Cohen, Yee Leung, Lyndal Anderson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2013
The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomasBeatrice Gini, Ciro Zanca, Deliang Guo, et al.Journal of Synchrotron Radiation|August 20, 2013
The Materials Science beamline upgrade at the Swiss Light SourceP R Willmott, D Meister, S J Leake, et al.Anesthesia and Analgesia|October 16, 2019
Society of Cardiovascular Anesthesiologists Clinical Practice Improvement Advisory for Management of Perioperative Bleeding and Hemostasis in Cardiac Surgery PatientsJacob Raphael, C David Mazer, Sudhakar Subramani, et al.Nature Medicine|September 22, 2015
ACF chromatin-remodeling complex mediates stress-induced depressive-like behaviorHaoSheng Sun, Diane M Damez-Werno, Kimberly N Scobie, et al.Nature|December 10, 2020
Histone H1 loss drives lymphoma by disrupting 3D chromatin architectureNevin Yusufova, Andreas Kloetgen, Matt Teater, et al.Chemical Science|November 11, 2021
Discovery of SARS-CoV-2 Mpro peptide inhibitors from modelling substrate and ligand bindingH T Henry Chan, Marc A Moesser, Rebecca K Walters, et al.Scientific Reports|June 25, 2021
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.International Journal of Particle Therapy|July 21, 2021
Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution ExperienceG Brandon Gunn, Adam S Garden, Rong Ye, et al.Pageof 253